← Open Payments lookup

DEANA SCHWARTZKOPF: Open Payments

NPI 1982099685 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$303 in 10 payments from 10 companies in 2025. Trend: 2023 $63 · 2024 $62 · 2025 $303

Food & beverage: $191Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.1$111
ABBVIE INC.1$30
Otsuka America Pharmaceutical, Inc.1$27
Vanda Pharmaceuticals Inc.1$25
Neurocrine BioSciences, Inc.1$21
Axsome Therapeutics, Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
E.R. Squibb & Sons, L.L.C.1$18
Alkermes, Inc.1$16
Collegium Pharmaceutical, Inc.1$14

Products named: VRAYLAR, REXULTI, FANAPT, INGREZZA, Auvelity, CAPLYTA, COBENFY, ARISTADA.

Industry payments across KS — which companies pay providers there.